United States · FDA National Drug Code directory
GLASSIA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0944-2884_312a9f40-d4bd-4cc2-810a-2df7d7baead8
- Product NDC
- 0944-2884
- Form
- INJECTION, SOLUTION
- Composition / generic term
- ALPHA.1-PROTEINASE INHIBITOR HUMAN
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20100701
- Source listing expiry
- 20261231
Source-listed ingredients
- .ALPHA.1-PROTEINASE INHIBITOR HUMAN — 1 g/50mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, GLASS in 1 CARTON (0944-2884-01) / 50 mL in 1 VIAL, GLASS (0944-2884-02) · 0944-2884-01
- 1 VIAL, GLASS in 1 CARTON (0944-2884-03) / 200 mL in 1 VIAL, GLASS (0944-2884-04) · 0944-2884-03
- 1 VIAL, GLASS in 1 CARTON (0944-2884-05) / 250 mL in 1 VIAL, GLASS (0944-2884-06) · 0944-2884-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →